Key Points
- CFO Luis Andre Carpintero Blanco sold 10,000 shares on April 8 at an average price of $15.20 for $152,000, cutting his ownership by 16.37% to 51,103 shares, according to an SEC filing.
- Afya beat EPS estimates with $0.41 per share but missed revenue expectations ($147.08M vs. $174.74M), and the company trades with a market cap of $1.41B and a PE of 10.32.
- Afya paid an annual dividend of $0.656 on April 6 (reported yield 433.0%) and carries a Wall Street consensus rating of "Hold" with a $17.30 price target.
Afya Limited (NASDAQ:AFYA - Get Free Report) CFO Luis Andre Carpintero Blanco sold 10,000 shares of Afya stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $15.20, for a total value of $152,000.00. Following the completion of the sale, the chief financial officer owned 51,103 shares in the company, valued at approximately $776,765.60. This trade represents a 16.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Afya Stock Down 1.1%
Afya stock opened at $15.07 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.20 and a quick ratio of 2.20. Afya Limited has a 1-year low of $13.00 and a 1-year high of $19.90. The company has a market cap of $1.41 billion, a PE ratio of 10.32, a price-to-earnings-growth ratio of 0.68 and a beta of 0.48. The stock's 50 day moving average price is $14.48 and its 200 day moving average price is $14.69.
Afya (NASDAQ:AFYA - Get Free Report) last posted its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.05. Afya had a return on equity of 18.77% and a net margin of 20.31%.The firm had revenue of $147.08 million for the quarter, compared to the consensus estimate of $174.74 million. On average, sell-side analysts predict that Afya Limited will post 1.52 EPS for the current fiscal year.
Afya Announces Dividend
The firm also recently declared an annual dividend, which was paid on Monday, April 6th. Investors of record on Wednesday, March 25th were paid a $0.656 dividend. The ex-dividend date was Wednesday, March 25th. This represents a dividend yield of 433.0%. Afya's payout ratio is 45.21%.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the company. Weiss Ratings restated a "hold (c)" rating on shares of Afya in a research note on Wednesday, January 21st. JPMorgan Chase & Co. restated a "neutral" rating and issued a $22.00 price target (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Bank of America downgraded Afya from a "buy" rating to a "neutral" rating and decreased their price target for the company from $22.00 to $17.00 in a research note on Tuesday, February 24th. Zacks Research raised Afya from a "hold" rating to a "strong-buy" rating in a report on Tuesday. Finally, Sanford C. Bernstein raised Afya to a "market perform" rating in a report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat, Afya has a consensus rating of "Hold" and a consensus price target of $17.30.
Check Out Our Latest Research Report on Afya
Hedge Funds Weigh In On Afya
Several hedge funds and other institutional investors have recently bought and sold shares of the company. XTX Topco Ltd acquired a new position in Afya during the fourth quarter worth $215,000. Mangrove Partners IM LLC acquired a new position in Afya during the fourth quarter worth $197,000. State Street Corp raised its holdings in Afya by 25.8% during the fourth quarter. State Street Corp now owns 126,914 shares of the company's stock worth $1,955,000 after purchasing an additional 26,005 shares during the last quarter. Campbell & CO Investment Adviser LLC raised its holdings in Afya by 45.3% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company's stock worth $612,000 after purchasing an additional 12,365 shares during the last quarter. Finally, Banco BTG Pactual S.A. acquired a new position in Afya during the fourth quarter worth $462,000. 88.02% of the stock is owned by institutional investors and hedge funds.
More Afya News
Here are the key news stories impacting Afya this week:
- Positive Sentiment: Short interest fell materially in March — short interest declined about 14.1% to 541,994 shares as of March 31, leaving only ~0.6% of float shorted and a days-to-cover of ~4.4. Lower short interest reduces short pressure and can support upside or limit downside volatility.
- Positive Sentiment: Zacks upgraded Afya from "hold" to "strong-buy", giving institutional and retail investors a fresh buy-side signal that can attract flows. Zacks upgrade
- Positive Sentiment: The company paid an annual dividend on April 6 ($0.656 per share). The payout returns cash to shareholders and can support investor demand, particularly for income-oriented holders. MarketBeat dividend/coverage
- Neutral Sentiment: Institutional activity: several funds established or increased positions in Q4 (State Street, XTX Topco, Mangrove Partners, etc.). High institutional ownership (~88%) can stabilize stock but also concentrate flows. MarketBeat institutional holdings
- Negative Sentiment: Large insider sale by VP Lelio De Souza Junior — sold 26,753 shares (~$400k) on April 7, reducing his stake by ~62%. Large insider reductions can be perceived negatively by investors and may weigh on near-term sentiment. SEC filing - De Souza Jr sale
- Negative Sentiment: Smaller insider sale by VP De Sousa Anibal Jose Grifo — sold 5,000 shares (~$76k) on April 7 (10% reduction in his position). While smaller than the other sale, it adds to insider-decrease headlines. InsiderTrades - De Sousa sale
Afya Company Profile
(
Get Free Report)
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
